Abstract
Lymph node status is a strong predictor of outcome for lung adenocarcinoma (AdC) patients. To explore novel potential protein markers for predicting lymph node metastasis of lung AdC, differential proteomic analysis on microdissected cancer cells from primary lung AdC and matched lymph node (LN) metastatic tissues by laser capture microdissection (LCM) was conducted using two-dimensional differential in-gel electrophoresis (2D-DIGE) coupled with mass spectrometry (MS). Annexins including annexin-1, annexin-2 and annexin-3 were identified and found to be overexpressed in matched LN metastatic tissues compared to primary lung AdC. Furthermore, differential expression levels of the three annexins were evaluated in paraffin-embedded 188 primary lung AdC tissues and 65 matched positive lymph node specimens using immunohistochemistry. High expression of annexin-1, annexin-2, and annexin-3 was all frequently observed in matched positive lymph node tissues compared to primary lung AdC. In primary lung AdC, expression levels of the three annexins in primary lymph node-positive AdC tissues were higher than primary lymph node-negative AdC tissues. Multivariate logistic regression analysis indicated annexin-1, annexin-2, and annexin-3 were all significant risk factors for lymph node metastasis. Furthermore, statistical analysis indicated that the concomitant expression of annexin-1/annexin-2, annexin-1/annexin-3, or annexin-2/annexin-3 and combined expression of all three markers had stronger correlation with lymph node metastasis. Our results suggest that annexin-1, annexin-2, and annexin-3 are identified as potential biomarkers associated with lymph node metastasis in lung AdC.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12032-010-9761-3/MediaObjects/12032_2010_9761_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12032-010-9761-3/MediaObjects/12032_2010_9761_Fig2_HTML.jpg)
Similar content being viewed by others
References
Little AG, et al. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57(3):253–60.
Liao ML, et al. Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations. Zhonghua Yi Xue Za Zhi. 2007;87(27):1876–80.
Jemal A, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30.
Giese A, et al. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21(8):1624–36.
Yoshida BA, et al. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst. 2000;92(21):1717–30.
Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer. 1997;80(8 Suppl):1529–37.
Van den Bergh G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol. 2004;15(1):38–43.
Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82(2):331–71.
Rescher U, Gerke V. Annexins—unique membrane binding proteins with diverse functions. J Cell Sci. 2004;117(Pt 13):2631–9.
Cheng AL, et al. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res. 2008;7(6):2415–26.
Yang YX, et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics. 2006;6(6):2009–21.
Yang F, et al. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res. 2007;6(2):751–8.
Cheng A-L et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res 2008;14(2):435–5.
Mai J, et al. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem. 2000;275(17):12806–12.
Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. Faseb J. 2007;21(4):968–75.
Chiang Y, et al. Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem. 1999;199(1–2):139–47.
Cole SP, et al. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer. 1992;65(4):498–502.
Emoto K, et al. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer. 2001;92(6):1419–26.
Wang KL, et al. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res. 2006;12(15):4598–604.
Babbin BA, et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 2006;281(28):19588–99.
Liang L, Qu L, Ding Y. Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials. Cancer Invest. 2007;25(6):427–34.
Dai Z, et al. Identification and analysis of altered alpha1, 6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics. 2006;6(21):5857–67.
Wang KL, et al. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res. 2006;12(15):4598–604.
Chen ZG. Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer. Curr Cancer Drug Targets. 2007;7(7):613–22.
Vishwanatha JK, et al. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis. 1993;14(12):2575–9.
Tanaka T, et al. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene. 2004;23(22):3980–9.
Vellucci VF, Germino, FJ Reiss M. Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization. Gene 1995;166(2):213–20.
Semov A, et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with annexin II and accelerated plasmin formation. J Biol Chem. 2005;280(21):20833–41.
Harashima M, et al. Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration. J Biochem. 2008;143(4):537–45.
Madoz-Gurpide J, et al. Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. Mol Cell Proteomics. 2006;5(8):1471–83.
Park JE, et al. Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun. 2005;337(4):1283–7.
Yao H, et al. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer. 2009;65(1):41–8.
Acknowledgments
This work was supported by a grant from National Key Basic Research Program of China (2001CB510207), the Fundamental Research Funds for the Central Universities (2010121104), Outstanding Scholars of New Era from Ministry of Education of China (2002-48), key research program from Science and Technology Committee of Hunan, China (04XK1001-1, 05SK1004-1), and key research program from Public Health Bureau of Hunan Province, China (Z02-04).
Conflicts of interest
No conflicts of interest are declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, YF., Chen, YH., Li, MY. et al. Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma. Med Oncol 29, 174–184 (2012). https://doi.org/10.1007/s12032-010-9761-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-010-9761-3